Sinopharm receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sinopharm Group Co Ltd (1099)
Track today's live Sinopharm (1099) share price, performance and key data on this page with our current Hong Kong:1099 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Sinopharm share price on the Hong Kong exchange. Use the dropdown to switch exchange for the 1099 share price, head to our technical summary section, which provides analysis on Sinopharm share price buy/sell indicators using real-time data (or discuss the Sinopharm (1099) stock price today with other investors in the Sinopharm HK share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current HK:1099 share price (ISIN: CNE100000FN7) to enhance your trading decisions with our free investment tools and resources.
What Is the Sinopharm Group Co Ltd Share Price Today?
The Sinopharm share price today is 14.70.
What Is the Stock Symbol for Sinopharm Group Co Ltd
The stock symbol (or 'ticker') for 01099 is "1099."
What Stock Exchange Does Sinopharm Group Co Ltd Trade On?
01099 is listed and trades on the Hong Kong stock exchange.
Is Sinopharm Group Co Ltd a Good Stock to Buy?
Determining whether Sinopharm (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current HK:1099 share price (ISIN: CNE100000FN7) to enhance your trading decisions with our free investment tools and resources.
What Is the Sinopharm Group Co Ltd Share Price Today?
The Sinopharm share price today is 14.70.
What Is the Stock Symbol for Sinopharm Group Co Ltd
The stock symbol (or 'ticker') for 01099 is "1099."
What Stock Exchange Does Sinopharm Group Co Ltd Trade On?
01099 is listed and trades on the Hong Kong stock exchange.
Is Sinopharm Group Co Ltd a Good Stock to Buy?
Determining whether Sinopharm (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Currency in HKD
14.70
-0.15(-1.01%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.67
15.01
52 wk Range
14.55
22.34
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.6715.01
52 wk Range
14.5522.34
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.32%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.32%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1099 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
21.14
Upside
+43.83%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low earnings multiple
Sinopharm receives Investment Bank Analyst Rating Update- Investing.com
Pro
Sinopharm receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Sinopharm receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Sinopharm receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Sinopharm receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Sinopharm receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
10 Buy
5 Hold
0 Sell
Ratings:
15 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 21.14
(+43.83% Upside)
Earnings
Latest Release
20/08/2026
EPS / Forecast
0.64 / 1.18
Revenue / Forecast
142.03B / --
Compare 1099 to Peers and Sector
Metrics to compare | 1099 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1099PeersSector | |
|---|---|---|---|---|
P/E Ratio | 5.5x | 14.0x | −0.3x | |
PEG Ratio | 1.39 | −0.37 | 0.00 | |
Price/Book | 0.5x | 1.0x | 2.6x | |
Price / LTM Sales | 0.1x | 0.9x | 3.0x | |
Upside (Analyst Target) | 42.3% | 48.3% | 57.9% | |
Fair Value Upside | Unlock | 39.0% | 7.6% | Unlock |
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. Sinopharm Group Co. Ltd. was founded in 2003 and is headquartered in Shanghai, the People’s Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Sinopharm (Hong Kong: 1099) Share Price Today?
The Sinopharm stock price today is 14.70 HKD.
What Stock Exchange Does Sinopharm (1099) Trade On?
Sinopharm is listed and trades on the Hong Kong Stock Exchange.
What Is the Ticker (Stock Symbol) for Sinopharm?
The stock symbol (also called a 'ticker') for Sinopharm is "1099."
Does Sinopharm Pay Dividends? What’s The Current 1099 Dividend Yield?
Yes, 1099 Pays Dividends to its Shareholders. The current Sinopharm dividend yield is 5.32%.
What Is the Current Sinopharm Market Capitalisation?
As of today, Sinopharm (Hong Kong: 1099) market cap is 46.34B HKD.
What Is Sinopharm's (1099) Earnings Per Share (TTM)?
The Sinopharm EPS is currently 2.27 (Trailing Twelve Months).
When Is the Next Sinopharm Earnings Date?
Sinopharm's next earnings report will be released on 02/11/2026.
Is 1099 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Sinopharm moving averages and other technical indicators, the daily buy/sell signal for 1099 stock is Strong Sell.
How Many Times Has Sinopharm Stock Split?
Sinopharm has split 0 times. (See the 1099 stock split history page for full effective split date and price information.)
How Many Employees Does Sinopharm Have?
Sinopharm has 90447 employees, based on their latest Companies House report.
What is the current trading status of Sinopharm (Hong Kong: 1099)?
As of 08/10/2026, Sinopharm (1099) is trading at a share price of 14.70 HKD, with a previous close of 14.85 HKD. The stock has fluctuated within a day range of 14.67 HKD to 15.01 HKD, while its 52-week range spans from 14.55 HKD to 22.34 HKD.
What Is Sinopharm (1099) Price Target According to Analysts?
The average 12-month price target for Sinopharm is 21.14 HKD, with a high estimate of 27.80262234 HKD and a low estimate of 17.07445563 HKD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +43.83% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.